Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Derek Sheader
Latest news
-
LifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
-
LifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
-
Innovative home monitoring service aims to improve care for patients with dementia